Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Exploratory Phase 2A, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess Mechanism Of Action (MOA) Of CP-690,550 In The Skin When Administered Orally At 10 Mg Twice Daily (BID) For 12 Weeks In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Next Previous
Trial Profile

An Exploratory Phase 2A, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess Mechanism Of Action (MOA) Of CP-690,550 In The Skin When Administered Orally At 10 Mg Twice Daily (BID) For 12 Weeks In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 15 Apr 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tofacitinib (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Pfizer

Most Recent Events

  • 01 Apr 2016 Results published in the Journal of Allergy and Clinical Immunology
  • 23 Oct 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
  • 15 Oct 2013 Planned end date changed from 1 Sep 2014 to 1 Mar 2015 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top